Component

Brain-to-blood efflux transport of GABA

Brain-to-blood efflux transport of GABA. Species, exposure and limitations are retained in each linked claim.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. Study of brain to blood efflux transport of carbon-14 GABA after loading the brain by vascular perfusion revealed that the half-time of elimination was significantly shorter in spontaneously hypertensive rats at 5.35 plus or minus 0.66 minutes than in Wistar Kyoto rats at 14.83 plus or minus 1.94 minutes, the faster efflux might at least partially compensate for increased uptake and preserve the protective function of the barrier towards GABA, and systemic infusion of GABA within a wide range of administered doses from 0.004 to 5.00 milligrams per kilogram produced an increase in cerebrospinal fluid GABA concentration from around 0.5 micromolar to only 11 micromolar.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/gaba-research/16616765.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "550c910f870ffc48b56fbcfe95555a4fec6441bdbef7b1369ef79d1bcba6df5d", "start_char": 0, "end_char": 1941, "text_sha256": "550c910f870ffc48b56fbcfe95555a4fec6441bdbef7b1369ef79d1bcba6df5d"}
    experimental_model
    In situ brain perfusion with efflux measurement and cerebrospinal fluid sampling across a range of systemic doses
    exposure
    Carbon-14 GABA by bilateral in situ brain perfusion, and systemic GABA infusion from 0.004 to 5.00 milligrams per kilogram
    limitations
    Anaesthetised rats, and the comparison is between hypertensive and normotensive strains. The dose-ranging cerebrospinal fluid measurement is the part that bears on oral supplementation.
    nutrient_topic
    GABA research collection; topical membership is not evidence of a direct clinical effect, and the sign of a GABA response depends on the chloride gradient of the cell it was measured in. · Gamma-aminobutyric acid
    organism
    Rat
    plain_language
    The brain actively pumps this molecule back out, and flooding the bloodstream with it barely shifts the concentration inside.
    primary_references
    [gb-p16616765] Increased brain uptake and brain to blood efflux transport of 14C-GABA in spontaneously hypertensive rats. (2006). https://pubmed.ncbi.nlm.nih.gov/16616765/ DOI: 10.1016/j.lfs.2006.02.039
    tissue_or_cell_type
    Brain, cerebrospinal fluid and cerebral capillaries

    GABA: a ligand with no sign of its own, the cofactor that limits its synthesis, the barrier that keeps it out of the brain, and the immune settings where the same molecule protects and harms (2026-09-22) · lines 339–350

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · In situ brain perfusion with efflux measurement and cerebrospinal fluid sampling across a range of systemic doses · source_derived_draft · unverified_draft

    ### gb-the-brain-pushes-gaba-back-out Study of brain to blood efflux transport of carbon-14 GABA after loading the brain by vascular perfusion revealed that the half-time of elimination was significantly shorter in spontaneously hypertensive rats at 5.35 plus or minus 0.66 minutes than in Wistar Kyoto rats at 14.83 plus or minus 1.94 minutes, the faster efflux might at least partially compensate for increased uptake and preserve the protective function of the barrier towards GABA, and systemic infusion of GABA within a wide range of administered doses from 0.004 to 5.00 milligrams per kilogram produced an increase in cerebrospinal fluid GABA concentration from around 0.5 micromolar to only 11 micromolar. Condition category: normal nutrient_topic: GABA research collection; topical membership is not evidence of a direct clinical effect, and the sign of a GABA response depends on the chloride gradient of the cell it was measured in. plain_language: The brain actively pumps this molecule back out, and flooding the bloodstream with it barely shifts the concentration inside. organism: Rat tissue_or_cell_type: Brain, cerebrospinal fluid and cerebral capillaries experimental_model: In situ brain perfusion with efflux measurement and cerebrospinal fluid sampling across a range of systemic doses limitations: Anaesthetised rats, and the comparison is between hypertensive and normotensive strains. The dose-ranging cerebrospinal fluid measurement is the part that bears on oral supplementation. exposure: Carbon-14 GABA by bilateral in situ brain perfusion, and systemic GABA infusion from 0.004 to 5.00 milligrams per kilogram evidence_span: {"source_cache": "artifacts/gaba-research/16616765.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "550c910f870ffc48b56fbcfe95555a4fec6441bdbef7b1369ef79d1bcba6df5d", "start_char": 0, "end_char": 1941, "text_sha256": "550c910f870ffc48b56fbcfe95555a4fec6441bdbef7b1369ef79d1bcba6df5d"} [gb-p16616765] Increased brain uptake and brain to blood efflux transport of 14C-GABA in spontaneously hypertensive rats. (2006). https://pubmed.ncbi.nlm.nih.gov/16616765/ DOI: 10.1016/j.lfs.2006.02.039
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards